title: Lone atrial fibrillation: more than meets the eye.
abstract: Doxorubicin has been used as a chemotherapeutic agent for over 30 years. Its cardiac toxicity has been known for over 20 years. In recent years, delayed-onset cardiac toxicity has been described as yet another cardiac complication of doxorubicin and other anthracyclines. The following case is felt to represent such an example.
authors.affiliation: MetLife, 440 U.S. Highway 22, Grande Commons Building, Bridgewater, NJ 08807, USA.
authors.forename: Robert A
authors.initials: RA
authors.lastname: Coates
mesh_terms: D000208:Acute Disease; D000328:Adult; D001281:Atrial Fibrillation / Q000139:chemically induced*; D009202:Cardiomyopathies / Q000139:chemically induced; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D004562:Electrocardiography; D006801:Humans; D007352:Insurance, Life; D008297:Male; D012208:Rhabdomyosarcoma / Q000188:drug therapy
chemical_list: D004317:Doxorubicin